Thymosin alpha-1 enhanced immune reconstitution after haploidentical hematopoietic transplantation, reducing infection risk during the critical immune-depleted period — peptide immunotherapy for transplant patients.
Key findingThymosin alpha-1 enhanced immune reconstitution after haploidentical hematopoietic transplantation, reducing infection risk during the critical immune
What the researchers found
Thymosin alpha-1 enhanced immune reconstitution after haploidentical hematopoietic transplantation, reducing infection risk during the critical immune-depleted period — peptide immunotherapy for transplant patients.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.
Annals of the New York Academy of Sciences, 1194, 153-61
Citation
Perruccio, Katia; Bonifazi, Pierluigi; Topini, Fabiana; Tosti, Antonella; Bozza, Silvia; Aloisi, Teresa; Carotti, Alessandra; Aversa, Franco; Martelli, Massimo F; Romani, Luigina; Velardi, Andrea. (2010). Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.. Annals of the New York Academy of Sciences, 1194, 153-61. https://doi.org/10.1111/j.1749-6632.2010.05486.x